A European consortium, led by Prof. Hans Gelderblom of Leiden University Medical Center (LUMC) on behalf of the Drug Rediscovery Protocol team, will receive 3 million euros to tailor future cancer treatments to the genetic profile of the tumour. A European follow-up grant of 6 million euros has now also been awarded.
Read more&w=710&h=710)
&w=710&h=710)
&w=180&h=180)
&w=180&h=180)
&w=180&h=180)